PPD
Also known as: Alavita Pharmaceuticals Inc | Pharmaceutical Product Development (PPD) | Pharmaceutical Product Development (PPD), Inc | PPD | PPD Austin | PPD Austin, TX | PPD Australia Pty Ltd | PPD DEVELOPMENT, LP | PPD, Incorporated | PPD, Medical Director | PPD Phase I Clinic | PPD Phase I Clinic - Orlando | PPD Phase I unit | PPD Phase I Unit
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2000Last known activity
Feb 18, 2026
Timeline
1980s
- Jan 1, 1985
PPD— Founded
2000s
- Jan 30, 2003
- Apr 21, 2009
Magen BioSciences— Acquired
- Oct 27, 2009
Excel PharmaStudies, Inc.— Acquired
- Nov 15, 2009
BioDuro, LLC— Acquired
2010s
- Aug 28, 2013
Acurian, Inc— Acquired
- Aug 28, 2014
Heidelberg Clinical Research Centre— Acquired
- Mar 3, 2016
Research Across America— Acquired
- Jun 6, 2016
Synexus— Acquired
- Aug 10, 2016
Evidera Corporation— Acquired
2020s
- Apr 15, 2021
Thermo Fisher Scientific— Acquired By
Drugs by trial phase (249 distinct, 234 trials)
Phase 4 (9 own, 4 via acquisition)
Phase 3 (61 own, 16 via acquisition)
Phase 2 (65 own, 23 via acquisition)
Phase 1 (62 own, 0 via acquisition)
Other trials (1 own, 8 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Kidney Injury
- Acute Pain
- Adenocarcinoma
- Anemia
- Angioedema
- Ankle Injuries
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Asthma
- Atrophy
- Atypical Squamous Cells of the Cervix
- Bipolar Disorder
- Bursitis
- Candidiasis
- Candidiasis, Vulvovaginal
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cardiovascular Diseases
- Carpal Tunnel Syndrome
- Catheter-Related Infections
- Colonic Polyps
- Colorectal Neoplasms
- Communicable Diseases
- Condylomata Acuminata
- Contusions
- Coronary Artery Disease
- Coronary Disease
- Crohn Disease
- Dehydration
- Dengue
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Disease
- Elbow Tendinopathy
- Esophagitis
- Familial Primary Pulmonary Hypertension
- Fatty Liver
- Flaviviridae Infections
- Flavivirus Infections
- Glaucoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- HIV Infections
- Hypertension
- Hypertension, Pulmonary
- Hypogonadism
- Immune System Diseases
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Influenza, Human
- Influenza in Birds
- Irritable Bowel Syndrome
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Liver Diseases
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Macular Degeneration
- Malnutrition
- Migraine Disorders
- Multiple System Atrophy
- Myocardial Infarction
- Myocardial Ischemia
- Myositis
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Obstetric Labor, Premature
- Ocular Hypertension
- Onychomycosis
- Osteoarthritis
- Pancreatic Neoplasms
- Papilloma
- Parkinson Disease
- Peripheral Nervous System Diseases
- Pneumonia
- Pneumonia, Pneumococcal
- Prostatic Neoplasms
- Psoriasis
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Eosinophilia
Subsidiaries (9 direct, 12 total across the full acquisition tree)
Recent trials (50)
- NCT07015996CollaboratorPhase 2Feb 18, 2026
- NCT07247266CollaboratorPhase 1Dec 31, 2025
- NCT06816433CollaboratorPhase 2Nov 30, 2025
- NCT07053800CollaboratorPhase 2Sep 30, 2025
- NCT06701669Lead sponsorPhase 2Jan 6, 2025
- NCT06701682Lead sponsorPhase 2Dec 27, 2024
- NCT06703073Lead sponsorPhase 2Dec 20, 2024
- NCT06701656Lead sponsorPhase 2Dec 20, 2024
- NCT06594068CollaboratorPhase 4Nov 29, 2024
- NCT06343298CollaboratorPhase 2Sep 25, 2024
- NCT06422767CollaboratorPhase 1Aug 14, 2024
- NCT06398730CollaboratorPhase 1Jul 2, 2024
- NCT06247241CollaboratorPhase 2Apr 30, 2024
- NCT06134362CollaboratorPhase 3Jan 5, 2024
- NCT05948553CollaboratorPhase 2Nov 2, 2023
Details
- Founded
- Wilmington, NC, US Jan 1, 1985
- Last known activity
- Feb 18, 2026